Figure 1
From: Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study
Survival time of 24 patients in function of their averaged ApoC1 serum levels (mean value from all samples taken in an individual patient during the study period). The deviation of the regression line from horizontal is not significant.
